FP5Individual fellowship2001–2003
A biochemical and molecular approach to understanding the mechanisms of phosphatidylinositolphosphate kinase activation.
FP5 — Improving Human Research Potential
- Duration
- 2001-08-01 → 2003-07-31
- EU contribution
- €140,300
- Participants
- 1
- Scheme
- RGI
Lines connect the coordinator with its partners.
Participants
- THE NETHERLANDS CANCER INSTITUTE / ANTONI VAN LEEUWENHOEK HOSPITAL · AMSTERDAMCoordinatorNetherlands
Links
Data: CORDIS, © European Union